Check our latest news and where we are going to be soon.
Biohope presents results of novel IVD solution in Rheumatoid Arthritis at EULAR Congress 2023
Biohope has presented a poster with clinical study results of the novel ROS and Monocytes tests to measure in vitro the methotrexate response in early rheumatoid arthritis patients at the European Congress of Rheumatology 2023 (EULAR), [...]
New Hire: Sara Pascual joins Biohope as Access & Medical Affairs Director
We are thrilled to share that Sara Pascual just joined Biohope team as our Access & Medical Affairs Director. In this new role, Sara will lead the medical affairs and business development strategy of the company, focusing [...]
AST’s Cutting Edge of Transplantation 2023
Biohope reperesented by our CEO, Isabel Portero, participated in the CEOT 2023. American Society of Transplantation (AST) organized a new edition of "Cutting Edge of Transplantation" (CEoT) 2023 - Embracing New Frontiers in Transplantation. The event focused [...]
La sanidad española será la primera en poder ofrecer tratamientos personalizados a las personas trasplantadas de riñón
El test in-vitro Immunobiogram®, desarrollado por la biotech española Biohope, permite seleccionar la terapia más adecuada para cada paciente a partir de una muestra de sangre. Este importante avance médico se presentará en el Congreso de la [...]
52º Congreso de la Sociedad Española de Nefrología
Oral communication C Jimenez, D Valencia , Mo Lopez, Me Gonzalez, Ma Moreno, A De Santos, A Ortega, T Diez, I Portero, A Sánchez-fructuoso. “Caracterización de los parámetros del Immunobiogram, un nuevo método para la medida in [...]
The TRANSBIO study demonstrates the usefulness of Immunobiogram® for predicting the response to different immunosuppressive treatments in transplant recipients
The results have been published in the high-impact journal Transplant immunology. TRANSBIO, a multicenter, international clinical study, has demonstrated the correlation of the in-vitro measurement of the patient's pharmacodynamic response to immunosuppressive drugs, using the Immunobiogram® diagnostic [...]
The CDTI awards Biohope one of the grants, funded by NextGenerationEU program, for companies distinguished with the European Seal of Excellence.
Biohope has been awarded one of the grants from the Center for the Development of Industrial Technology (CDTI), aimed at Spanish companies that have obtained the Seal of Excellence in the first call of the European Innovation [...]
Entrevista en Capital Radio: Biohope, la financiación de las Biotech y la búsqueda de fondos.
El lunes 23 de mayo de 2022, la Dra. Isabel Portero, CEO de Biohope, participó junto a Eva Martín Becerra, fundadora de Kinrel, en el programa Biotecnología Capital, de Capital Radio. Durante el programa, dirigido por [...]
Biohope celebra 7 años de hitos conseguidos y mira al futuro de la biotecnología española con optimismo
Durante los 7 años de vida de Biohope se han cumplido hitos científico-tecnológicos, regulatorios y comerciales de gran relevancia. El inminente lanzamiento del primer producto de Biohope y la consolidación del pipeline de proyectos conforman los principales retos [...]
BIOHOPE will participate as biotechnology presenting company in the Anglonordic Life Science Conference
The Anglonordic Life Science Conference is an exclusive event for European investors and R&D companies, mainly proceeding from the Nordics and the UK. Biohope has been selected by the Spanish Institute for Foreign Trade (ICEX) to participate, [...]
